Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Total Liabilities (2021 - 2025)

Historic Total Liabilities for Generation Bio (GBIO) over the last 5 years, with Q3 2025 value amounting to $71.3 million.

  • Generation Bio's Total Liabilities fell 5057.85% to $71.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.3 million, marking a year-over-year decrease of 5057.85%. This contributed to the annual value of $145.0 million for FY2024, which is 1552.0% down from last year.
  • Generation Bio's Total Liabilities amounted to $71.3 million in Q3 2025, which was down 5057.85% from $125.3 million recorded in Q2 2025.
  • Generation Bio's Total Liabilities' 5-year high stood at $171.6 million during Q4 2023, with a 5-year trough of $55.3 million in Q1 2021.
  • For the 5-year period, Generation Bio's Total Liabilities averaged around $114.7 million, with its median value being $125.3 million (2025).
  • Its Total Liabilities has fluctuated over the past 5 years, first surged by 8303.1% in 2023, then plummeted by 5057.85% in 2025.
  • Over the past 5 years, Generation Bio's Total Liabilities (Quarter) stood at $95.0 million in 2021, then fell by 1.32% to $93.8 million in 2022, then surged by 83.03% to $171.6 million in 2023, then fell by 15.52% to $145.0 million in 2024, then plummeted by 50.8% to $71.3 million in 2025.
  • Its Total Liabilities stands at $71.3 million for Q3 2025, versus $125.3 million for Q2 2025 and $128.0 million for Q1 2025.